A Darzi Fellowship for 2017/18 has been approved for University College London Hospitals NHS Foundation Trust Cancer Collaborative to work with Lloyds Pharmacy to evaluate the implications of delivering subcutaneous hormonal injections for breast and prostate cancer via a community pharmacist model. This is the first time that a Darzi Fellowship in Clinical Leadership will involve community pharmacy.
Steve Williamson, RPS cancer spokesperson and Chair of British Oncology Association said:
“The award of this fellowship to demonstrate that this new delivery model can be successful is a fantastic development. It shows how community pharmacy can work with hospital pharmacy to develop new treatment pathways for the benefits of patients.
"Currently cancer patients attend hospital every few weeks for a quick subcutaneous injection. Having the option to go to their local community pharmacy instead offers the patient greater choice and convenience. It also helps hospital chemotherapy wards manage their every increasing workload leaving more time for patients and finally its it is likely to reduce overall costs to the NHS.”